当前位置: 首页 > 期刊 > 《糖尿病新世界》 > 202012
编号:13835531
炎症指标的变化在糖尿病患者真菌感染诊断中的价值分析(3)
http://www.100md.com 2020年6月15日 《糖尿病新世界》 202012
     [7] Lin W,Huang H,Wen J,et al.The predictive value of procalcitonin for early detection of infection in elderly type 2 diabetes mellitus[J].J Infect and Chemotherapy,2019(19)pii: S1341-321X.

    [8] Gonzalez Del Castillo J,Wilson DC,Clemente-Callejo C, et al. Biomarkers and clinical scores to identify patient populations at risk of delayed antibiotic administration or intensive care admission[J].Crit Care[J]2019,29;23(1):335.

    [9] 鄧军杰.老年糖尿病患者合并感染后胰岛素泵强化治疗的有效性分析[J]. 糖尿病新世界,2018(5):43-44.

    [10] Pawan Sagar1, Ashwani Kumar, SV. Madhu, et al. How good is procalcitonin as a marker in case of sepsis in diabetes mellitus[J].Int J Diabetes Dev Ctries,2018,38(2):18510.

    [11] Martin GS, Mannino DM, Eaton S, et al. The epidemiology of sepsis in the United States from 1979 through 2000[J].N Engl J Med,2003,348(16):1546-54.

    [12] Falc o Gon?alves P, Menezes Falc?oL, Duque Pinheiro I. Procalcitonin as biomarker of infection: implications for evaluation and treatment[J].Am J Ther,2017,24(3):e243-e249.

    (收稿日期:2020-03-20), 百拇医药(袁运生 吴京兰 庄瑞强 蔡杰 黎锐发)
上一页1 2 3